150 related articles for article (PubMed ID: 37450487)
1. Dynamic susceptibility contrast perfusion-weighted and diffusion-weighted magnetic resonance imaging findings in pilocytic astrocytoma and H3.3 and H3.1 variant diffuse midline glioma, H3K27-altered.
Kurokawa R; Kurokawa M; Baba A; Kim J; Srinivasan A; Moritani T
PLoS One; 2023; 18(7):e0288412. PubMed ID: 37450487
[TBL] [Abstract][Full Text] [Related]
2. Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma.
Kurokawa R; Kurokawa M; Baba A; Ota Y; Kim J; Capizzano A; Srinivasan A; Moritani T
Eur Radiol; 2022 Jun; 32(6):3672-3682. PubMed ID: 35022811
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of pilocytic astrocytoma, medulloblastoma, and hemangioblastoma on diffusion-weighted and dynamic susceptibility contrast perfusion MRI.
Kurokawa R; Kurokawa M; Baba A; Kim J; Capizzano A; Bapuraj J; Srinivasan A; Moritani T
Medicine (Baltimore); 2022 Nov; 101(44):e31708. PubMed ID: 36343086
[TBL] [Abstract][Full Text] [Related]
4. Dynamic susceptibility contrast and diffusion-weighted MRI in posterior fossa pilocytic astrocytoma and medulloblastoma.
Kurokawa R; Umemura Y; Capizzano A; Kurokawa M; Baba A; Holmes A; Kim J; Ota Y; Srinivasan A; Moritani T
J Neuroimaging; 2022 May; 32(3):511-520. PubMed ID: 34997668
[TBL] [Abstract][Full Text] [Related]
5. Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging.
Xiao HF; Chen ZY; Lou X; Wang YL; Gui QP; Wang Y; Shi KN; Zhou ZY; Zheng DD; Wang DJ; Ma L
Eur Radiol; 2015 Dec; 25(12):3423-30. PubMed ID: 26002128
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of pilocytic and pilomyxoid astrocytomas using dynamic susceptibility contrast perfusion and diffusion weighted imaging.
Ho CY; Supakul N; Patel PU; Seit V; Groswald M; Cardinal J; Lin C; Kralik SF
Neuroradiology; 2020 Jan; 62(1):81-88. PubMed ID: 31676961
[TBL] [Abstract][Full Text] [Related]
7. Diffusion and perfusion imaging biomarkers of H3 K27M mutation status in diffuse midline gliomas.
Kathrani N; Chauhan RS; Kotwal A; Kulanthaivelu K; Bhat MD; Saini J; Prasad C; Chakrabarti D; Santosh V; Uppar AM; Srinivas D
Neuroradiology; 2022 Aug; 64(8):1519-1528. PubMed ID: 35083503
[TBL] [Abstract][Full Text] [Related]
8. Perfusion and diffusion-weighted imaging parameters: Comparison between pre- and postbiopsy MRI for high-grade glioma.
Kurokawa R; Baba A; Kurokawa M; Capizzano A; Ota Y; Kim J; Srinivasan A; Moritani T
Medicine (Baltimore); 2022 Sep; 101(35):e30183. PubMed ID: 36107564
[TBL] [Abstract][Full Text] [Related]
9. MR dynamic-susceptibility-contrast perfusion metrics in the presurgical discrimination of adult solitary intra-axial cerebellar tumors.
Pons-Escoda A; Garcia-Ruiz A; Garcia-Hidalgo C; Gil-Solsona R; Naval-Baudin P; Martin-Noguerol T; Fernandez-Coello A; Flores-Casaperalta S; Fernandez-Viñas M; Gago-Ferrero P; Oleaga L; Perez-Lopez R; Majos C
Eur Radiol; 2023 Dec; 33(12):9120-9129. PubMed ID: 37439938
[TBL] [Abstract][Full Text] [Related]
10. Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.
Latysheva A; Emblem KE; Brandal P; Vik-Mo EO; Pahnke J; Røysland K; Hald JK; Server A
Neuroradiology; 2019 May; 61(5):545-555. PubMed ID: 30712139
[TBL] [Abstract][Full Text] [Related]
11. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.
Yang X; Lin Y; Xing Z; She D; Su Y; Cao D
Acta Radiol; 2021 Dec; 62(12):1657-1665. PubMed ID: 33222488
[TBL] [Abstract][Full Text] [Related]
12. Radiogenomics of diffuse intrinsic pontine gliomas (DIPGs): correlation of histological and biological characteristics with multimodal MRI features.
Calmon R; Dangouloff-Ros V; Varlet P; Deroulers C; Philippe C; Debily MA; Castel D; Beccaria K; Blauwblomme T; Grevent D; Levy R; Roux CJ; Purcell Y; Saitovitch A; Zilbovicius M; Dufour C; Puget S; Grill J; Boddaert N
Eur Radiol; 2021 Dec; 31(12):8913-8924. PubMed ID: 34003354
[TBL] [Abstract][Full Text] [Related]
13. Radiologic findings and the molecular expression profile of diffuse midline glioma H3 K27M mutant.
Seong M; Kim ST; Noh JH; Kim YK; Kim HJ
Acta Radiol; 2021 Oct; 62(10):1404-1411. PubMed ID: 33175579
[TBL] [Abstract][Full Text] [Related]
14. Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis.
Aboian MS; Tong E; Solomon DA; Kline C; Gautam A; Vardapetyan A; Tamrazi B; Li Y; Jordan CD; Felton E; Weinberg B; Braunstein S; Mueller S; Cha S
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1804-1810. PubMed ID: 31694820
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements.
Chen H; Hu W; He H; Yang Y; Wen G; Lv X
Eur J Radiol; 2019 May; 114():152-159. PubMed ID: 31005167
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of perfusion- and diffusion-weighted imaging to differentiate between pilocytic astrocytomas and high-grade gliomas: a multicenter study in Japan.
Kikuchi K; Hiwatashi A; Togao O; Yamashita K; Kamei R; Kitajima M; Kanoto M; Takahashi H; Uchiyama Y; Harada M; Shinohara Y; Yoshiura T; Wakata Y; Honda H
Neuroradiology; 2018 Apr; 60(4):391-401. PubMed ID: 29450601
[TBL] [Abstract][Full Text] [Related]
17. Intracranial paragangliomas versus schwannomas: Role of dynamic susceptibility contrast perfusion and diffusion MRI.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
J Neuroimaging; 2022 Sep; 32(5):875-883. PubMed ID: 35562184
[TBL] [Abstract][Full Text] [Related]
18. Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI.
Cindil E; Sendur HN; Cerit MN; Erdogan N; Celebi F; Dag N; Celtikci E; Inan A; Oner Y; Tali T
Acad Radiol; 2022 Mar; 29 Suppl 3():S52-S62. PubMed ID: 33685792
[TBL] [Abstract][Full Text] [Related]
19. Advanced MR imaging and
Piccardo A; Tortora D; Mascelli S; Severino M; Piatelli G; Consales A; Pescetto M; Biassoni V; Schiavello E; Massollo M; Verrico A; Milanaccio C; Garrè ML; Rossi A; Morana G
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1685-1694. PubMed ID: 31030232
[TBL] [Abstract][Full Text] [Related]
20. Tectal Low-Grade Glioma with H3 K27M Mutation.
Sumi K; Shijo K; Igarashi T; Yamamuro S; Sasano M; Oshima H; Ishige T; Honma T; Yagasaki H; Yoshino A
World Neurosurg; 2020 Sep; 141():91-100. PubMed ID: 32505657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]